X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.3	1.57	9.19	26.75	16.16	28.01
Short-Term Investments	0.48	3.09	38.77	-	-	-
Cash & Short-Term Investments	5.78	4.66	47.96	26.75	16.16	28.01
Cash Growth	581.13%	-90.28%	79.30%	65.57%	-42.33%	-35.48%
Accounts Receivable	39.57	0.25	27.65	0.59	3.71	5.07
Other Receivables	29.62	10.86	16.33	28.56	14.12	18.19
Receivables	156.85	11.11	43.98	29.15	17.83	23.26
Inventory	7.37	2.22	11.87	6.76	13.09	35.12
Prepaid Expenses	4.89	0.7	3.19	1.43	1.54	3.28
Other Current Assets	180.38	283.03	0.17	7.09	6.51	9.8
Total Current Assets	355.26	301.72	107.17	71.19	55.12	99.47
Property, Plant & Equipment	200.69	98.72	596.29	213.87	173.56	294.62
Long-Term Investments	-	-	27.25	-	-	-
Goodwill	73.73	123.39	335.35	246.18	267.44	516.1
Other Intangible Assets	2.18	70.86	319.23	146.54	150.05	364.85
Long-Term Deferred Tax Assets	-	-	0.13	-	-	-
Other Long-Term Assets	8.82	14.63	28.93	61.6	53.92	45.55
Total Assets	640.68	609.31	1,414	739.39	700.09	1,321

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	75.21	38.44	46.65	28.22	29.54	71.01
Accrued Expenses	-	45.45	39.3	38.33	25.24	17.5
Short-Term Debt	119.42	183.21	251.86	293.24	340.34	301.54
Current Portion of Long-Term Debt	-	2.93	3.05	3.05	3.21	3.14
Current Portion of Leases	6.74	14.64	22.16	26.64	27.23	36.39
Current Unearned Revenue	1.2	0.37	6.12	1.68	0.38	0.3
Other Current Liabilities	70.53	40.77	64.14	35.02	31.17	28.05
Total Current Liabilities	273.1	325.81	433.26	426.2	457.12	457.94
Long-Term Debt	-	3.71	5.93	8.29	10.68	13.2
Long-Term Leases	3.09	35.86	71.57	83.81	91.51	114.78
Pension & Post-Retirement Benefits	6.37	6.59	5.4	3.25	2.3	6.95
Long-Term Deferred Tax Liabilities	-	10.61	64.88	27.88	29.01	34.65
Other Long-Term Liabilities	0.23	3.53	5.88	7.15	6.94	19.66
Total Liabilities	282.79	386.11	586.93	556.58	597.55	647.19

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	85,146	7,352	1,944	1,031	813.91	813.91
Retained Earnings	-2,211	-1,845	-1,376	-1,116	-968.77	-397.91
Comprehensive Income & Other	-82,640	-5,290	-53.66	268.5	257.4	257.4
Total Common Equity	294.99	216.62	513.52	182.8	102.54	673.4
Minority Interest	62.9	6.58	313.91	0	0	0
Shareholders' Equity	357.89	223.2	827.43	182.81	102.54	673.41
Total Liabilities & Equity	640.68	609.31	1,414	739.39	700.09	1,321

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	129.26	240.36	354.56	415.04	472.98	469.05
Net Cash (Debt)	-123.48	-235.69	-306.6	-388.29	-456.82	-441.04
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.03	-0.59	-1.67	-3.10	-3.93	-3.79
Filing Date Shares Outstanding	12,164	1,050	277.66	147.23	116.27	116.27
Total Common Shares Outstanding	12,164	1,050	277.66	147.23	116.27	116.27
Working Capital	82.16	-24.09	-326.09	-355.01	-402	-358.47
Book Value Per Share	0.02	0.21	1.85	1.24	0.88	5.79
Tangible Book Value	219.08	22.37	-141.06	-209.92	-314.95	-207.55
Tangible Book Value Per Share	0.02	0.02	-0.51	-1.43	-2.71	-1.79
Land	-	-	126	-	-	-
Buildings	-	63.21	109.74	-	-	-
Machinery	-	30.9	354.01	70.33	72.44	123.46
Construction In Progress	-	2.59	8.56	16.51	2.3	11.08

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error